Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis.

Walaszek K, Lower EE, Ziolkowski P, Weber GF.

Br J Cancer. 2018 Nov;119(10):1259-1266. doi: 10.1038/s41416-018-0228-1. Epub 2018 Oct 24.

PMID:
30353046
2.

Response.

Baughman RP, Lower EE, Kirkil G.

Chest. 2018 Jun;153(6):1507-1508. doi: 10.1016/j.chest.2018.02.035. No abstract available.

PMID:
29884261
3.

Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study.

Lower EE, Charif M, Bartelt M.

Cancer Chemother Pharmacol. 2018 Jul;82(1):165-170. doi: 10.1007/s00280-018-3607-7. Epub 2018 Jun 5.

PMID:
29869680
4.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
5.

Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Bickett AN, Lower EE, Baughman RP.

Chest. 2018 Nov;154(5):1052-1060. doi: 10.1016/j.chest.2018.05.003. Epub 2018 May 17.

PMID:
29778660
6.

Steroids for sarcoidosis: How much and for how long?

Baughman RP, Lower EE.

Respir Med. 2018 May;138S:S5-S6. doi: 10.1016/j.rmed.2017.12.009. Epub 2017 Dec 15. No abstract available.

PMID:
29276075
7.

HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.

Yang Y, Leonard M, Zhang Y, Zhao D, Mahmoud C, Khan S, Wang J, Lower EE, Zhang X.

Cancer Res. 2018 Jan 15;78(2):422-435. doi: 10.1158/0008-5472.CAN-17-1533. Epub 2017 Nov 29.

8.

HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.

Ruiz-Torres SJ, Benight NM, Karns RA, Lower EE, Guan JL, Waltz SE.

Oncotarget. 2017 Jul 22;8(35):58918-58933. doi: 10.18632/oncotarget.19441. eCollection 2017 Aug 29.

9.

Measuring sarcoidosis around the world: Using the same ruler.

Baughman RP, Lower EE.

Rev Port Pneumol (2006). 2017 Sep - Oct;23(5):247-248. doi: 10.1016/j.rppnen.2017.08.001. Epub 2017 Aug 23. No abstract available.

10.

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site.

Lower EE, Khan S, Kennedy D, Baughman RP.

Breast Cancer (Dove Med Press). 2017 Aug 2;9:515-520. doi: 10.2147/BCTT.S137709. eCollection 2017.

11.

Idiopathic granulomatous mastitis: A diagnostic and therapeutic challenge.

Freeman CM, Xia BT, Wilson GC, Lewis JD, Khan S, Lee SJ, Lower EE, Edwards MJ, Shaughnessy EA.

Am J Surg. 2017 Oct;214(4):701-706. doi: 10.1016/j.amjsurg.2017.07.002. Epub 2017 Jul 8.

PMID:
28739122
12.

Predictors of Mortality in Pulmonary Sarcoidosis.

Kirkil G, Lower EE, Baughman RP.

Chest. 2018 Jan;153(1):105-113. doi: 10.1016/j.chest.2017.07.008. Epub 2017 Jul 18.

PMID:
28728933
13.

Repository corticotropin for Chronic Pulmonary Sarcoidosis.

Baughman RP, Sweiss N, Keijsers R, Birring SS, Shipley R, Saketkoo LA, Lower EE.

Lung. 2017 Jun;195(3):313-322. doi: 10.1007/s00408-017-9994-4. Epub 2017 Mar 28.

14.

Clinical characteristics of patients with bone sarcoidosis.

Zhou Y, Lower EE, Li H, Farhey Y, Baughman RP.

Semin Arthritis Rheum. 2017 Aug;47(1):143-148. doi: 10.1016/j.semarthrit.2017.02.004. Epub 2017 Feb 10.

15.

Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival.

Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP.

Chest. 2017 Jan;151(1):139-148. doi: 10.1016/j.chest.2016.08.1457. Epub 2016 Sep 8.

PMID:
27614001
16.

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel.

Zhou Y, Lower EE, Li H, Baughman RP.

Respir Med Case Rep. 2015 Nov 19;17:5-7. doi: 10.1016/j.rmcr.2015.11.001. eCollection 2016.

17.

Clinical management of pulmonary sarcoidosis.

Zhou Y, Lower EE, Li H, Baughman RP.

Expert Rev Respir Med. 2016;10(5):577-91. doi: 10.1586/17476348.2016.1164602. Epub 2016 Mar 28. Review.

PMID:
26959110
18.

Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.

Baughman RP, Judson MA, Lower EE, Drent M, Costabel U, Flavin S, Lo KH, Barnathan ES; Sarcoidosis Investigators.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):289-95.

PMID:
26847095
19.

A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.

Baughman RP, Barney JB, O'Hare L, Lower EE.

Respir Med. 2016 Jan;110:66-72. doi: 10.1016/j.rmed.2015.11.007. Epub 2015 Nov 19.

20.

Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study.

Baughman RP, Culver DA, Jankovi V, Fischkoff S, Brockway G, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):106-14.

PMID:
26278689
21.

Clinical trials in pulmonary sarcoidosis.

Baughman RP, Lower EE, Saketkoo LA.

Curr Opin Pulm Med. 2015 Sep;21(5):525-31. doi: 10.1097/MCP.0000000000000193. Review.

PMID:
26176971
22.

Treatment of Sarcoidosis.

Baughman RP, Lower EE.

Clin Rev Allergy Immunol. 2015 Aug;49(1):79-92. doi: 10.1007/s12016-015-8492-9. Review.

PMID:
25989728
23.

Features of sarcoidosis associated with chronic disease.

Baughman RP, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):275-81.

PMID:
25591138
24.

Goldilocks, vitamin D and sarcoidosis.

Baughman RP, Lower EE.

Arthritis Res Ther. 2014;16(3):111.

25.

Medical therapy of sarcoidosis.

Baughman RP, Lower EE.

Semin Respir Crit Care Med. 2014 Jun;35(3):391-406. doi: 10.1055/s-0034-1376401. Epub 2014 Jul 9. Review.

PMID:
25007090
26.

Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis.

Carbone RG, Penna D, Baughman RP, Lower EE.

J Clin Imaging Sci. 2014 Apr 29;4:21. doi: 10.4103/2156-7514.131645. eCollection 2014.

27.

The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19-27.

PMID:
24751450
28.

Rituximab in the treatment of refractory pulmonary sarcoidosis.

Sweiss NJ, Lower EE, Mirsaeidi M, Dudek S, Garcia JG, Perkins D, Finn PW, Baughman RP.

Eur Respir J. 2014 May;43(5):1525-8. doi: 10.1183/09031936.00224513. Epub 2014 Jan 31. No abstract available.

29.

Sarcoidosis, fatigue, and sleep apnea.

Lower EE, Malhotra A, Sudurlescu V, Baughman RP.

Chest. 2013 Dec;144(6):1976-1977. doi: 10.1378/chest.13-1761. No abstract available.

30.

Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients.

Baughman RP, Lower EE.

Respir Med. 2013 Dec;107(12):2009-13. doi: 10.1016/j.rmed.2013.10.014. Epub 2013 Oct 22.

31.

Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.

Baughman RP, Culver DA, Cordova FC, Padilla M, Gibson KF, Lower EE, Engel PJ.

Chest. 2014 Apr;145(4):810-817. doi: 10.1378/chest.13-1766.

PMID:
24177203
32.

Calcium and vitamin D metabolism in sarcoidosis.

Baughman RP, Janovcik J, Ray M, Sweiss N, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Aug 1;30(2):113-20.

PMID:
24071882
33.

Effect of obesity on patient-reported outcomes in sarcoidosis.

Gvozdenovic BS, Mihailovic-Vucinic V, Vukovic M, Lower EE, Baughman RP, Dudvarski-Ilic A, Zugic V, Popevic S, Videnovic-Ivanov J, Filipovic S, Stjepanovic M, Omcikus M.

Int J Tuberc Lung Dis. 2013 Apr;17(4):559-64. doi: 10.5588/ijtld.12.0665.

PMID:
23485390
34.

Endpoints for clinical trials of sarcoidosis.

Baughman RP, Drent M, Culver DA, Grutters JC, Handa T, Humbert M, Judson MA, Lower EE, Mana J, Pereira CA, Prasse A, Sulica R, Valyere D, Vucinic V, Wells AU.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):90-8. Review.

PMID:
23461070
35.

Established and experimental medical therapy of pulmonary sarcoidosis.

Baughman RP, Nunes H, Sweiss NJ, Lower EE.

Eur Respir J. 2013 Jun;41(6):1424-38. doi: 10.1183/09031936.00060612. Epub 2013 Feb 8. Review.

36.

Management of ocular sarcoidosis.

Baughman RP, Lower EE, Ingledue R, Kaufman AH.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):26-33.

PMID:
23311120
37.

Rituximab for refractory granulomatous eye disease.

Lower EE, Baughman RP, Kaufman AH.

Clin Ophthalmol. 2012;6:1613-8. doi: 10.2147/OPTH.S35521. Epub 2012 Oct 5.

38.

Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.

Lower EE, Malhotra A, Surdulescu V, Baughman RP.

J Pain Symptom Manage. 2013 Feb;45(2):159-69. doi: 10.1016/j.jpainsymman.2012.02.016. Epub 2012 Aug 20.

39.

Pulmonary manifestations of sarcoidosis.

Baughman RP, Lower EE, Gibson K.

Presse Med. 2012 Jun;41(6 Pt 2):e289-302. doi: 10.1016/j.lpm.2012.03.019. Epub 2012 May 10. Review.

PMID:
22579234
40.

Sarcoidosis-associated fatigue.

Drent M, Lower EE, De Vries J.

Eur Respir J. 2012 Jul;40(1):255-63. doi: 10.1183/09031936.00002512. Epub 2012 Mar 22.

41.

Biomarker discordance: why it occurs and why it is important.

Lower EE, Khan S.

Cancer Biomark. 2012-2013;12(6):219-30. doi: 10.3233/CBM-130317. Review.

PMID:
23735942
42.

Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.

Baughman RP, Judson MA, Ingledue R, Craft NL, Lower EE.

Arch Dermatol. 2012 Feb;148(2):262-4. doi: 10.1001/archdermatol.2011.301. Epub 2011 Oct 17. No abstract available.

PMID:
22004880
43.

Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.

Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du Bois R, Grutters JC, Judson MA, Lambiri I, Lower EE, Muller-Quernheim J, Prasse A, Rizzato G, Rottoli P, Spagnolo P, Teirstein A.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):56-64.

PMID:
21796892
44.

Who dies from sarcoidosis and why?

Baughman RP, Lower EE.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1446-7. doi: 10.1164/rccm.201103-0409ED. No abstract available.

PMID:
21642253
45.

Bone health issues in sarcoidosis.

Sweiss NJ, Lower EE, Korsten P, Niewold TB, Favus MJ, Baughman RP.

Curr Rheumatol Rep. 2011 Jun;13(3):265-72. doi: 10.1007/s11926-011-0170-1. Review.

46.

Quality of life in sarcoidosis: assessment and management.

De Vries J, Lower EE, Drent M.

Semin Respir Crit Care Med. 2010 Aug;31(4):485-93. doi: 10.1055/s-0030-1262216. Epub 2010 Jul 27. Review.

PMID:
20665398
47.

Ocular sarcoidosis.

Baughman RP, Lower EE, Kaufman AH.

Semin Respir Crit Care Med. 2010 Aug;31(4):452-62. doi: 10.1055/s-0030-1262213. Epub 2010 Jul 27. Review.

PMID:
20665395
48.

Inhaled iloprost for sarcoidosis associated pulmonary hypertension.

Baughman RP, Judson MA, Lower EE, Highland K, Kwon S, Craft N, Engel PJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):110-20.

PMID:
20560291
49.

Fatigue in sarcoidosis: American versus Dutch patients.

de Kleijn WP, Elfferich MD, De Vries J, Jonker GJ, Lower EE, Baughman RP, King TE Jr, Drent M.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):92-7.

PMID:
20560289
50.

Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation.

Baughman RP, Engel PJ, Taylor L, Lower EE.

Chest. 2010 Nov;138(5):1078-85. doi: 10.1378/chest.09-2002. Epub 2010 Mar 26.

PMID:
20348196

Supplemental Content

Loading ...
Support Center